| Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model HJ Westeneng, TA Debray, AE Visser, RPA van Eijk, JPK Rooney, ... Lancet Neurology, 2018 | 507 | 2018 |
| Extracellular vesicles in neurodegenerative disease—pathogenesis to biomarkers AG Thompson, E Gray, SM Heman-Ackah, I Mäger, K Talbot, ... Nature Reviews Neurology 12 (6), 346-357, 2016 | 394 | 2016 |
| Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World … P Lewczuk, P Riederer, SE O’bryant, MM Verbeek, B Dubois, PJ Visser, ... The world journal of biological psychiatry 19 (4), 244-328, 2018 | 283 | 2018 |
| Whippits, nitrous oxide and the dangers of legal highs AG Thompson, MI Leite, MP Lunn, DLH Bennett Practical neurology 15 (3), 207-209, 2015 | 147 | 2015 |
| Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis AG Thompson, E Gray, ML Thézénas, PD Charles, S Evetts, MT Hu, ... Annals of neurology 83 (2), 258-268, 2018 | 133 | 2018 |
| Non-neuronal cells in amyotrophic lateral sclerosis—from pathogenesis to biomarkers BF Vahsen, E Gray, AG Thompson, O Ansorge, DC Anthony, SA Cowley, ... Nature Reviews Neurology 17 (6), 333-348, 2021 | 129 | 2021 |
| Astrocyte adenosine deaminase loss increases motor neuron toxicity in amyotrophic lateral sclerosis SP Allen, B Hall, LM Castelli, L Francis, R Woof, AP Siskos, E Kouloura, ... Brain 142 (3), 586-605, 2019 | 119 | 2019 |
| CSF chitinase proteins in amyotrophic lateral sclerosis AG Thompson, E Gray, A Bampton, D Raciborska, K Talbot, MR Turner Journal of Neurology, Neurosurgery & Psychiatry 90 (11), 1215-1220, 2019 | 99 | 2019 |
| Multicentre appraisal of amyotrophic lateral sclerosis biofluid biomarkers shows primacy of blood neurofilament light chain AG Thompson, E Gray, N Verber, Y Bobeva, V Lombardi, SR Shepheard, ... Brain communications 4 (1), fcac029, 2022 | 70 | 2022 |
| Identification of a potential non-coding RNA biomarker signature for amyotrophic lateral sclerosis G Joilin, E Gray, AG Thompson, Y Bobeva, K Talbot, J Weishaupt, ... Brain communications 2 (1), fcaa053, 2020 | 55 | 2020 |
| CSF extracellular vesicle proteomics demonstrates altered protein homeostasis in amyotrophic lateral sclerosis AG Thompson, E Gray, I Mäger, ML Thézénas, PD Charles, K Talbot, ... Clinical Proteomics 17, 1-12, 2020 | 47 | 2020 |
| Amyotrophic lateral sclerosis: the complex path to precision medicine K Talbot, E Feneberg, J Scaber, AG Thompson, MR Turner Journal of neurology 265, 2454-2462, 2018 | 47 | 2018 |
| UFLC‐derived CSF extracellular vesicle origin and proteome AG Thompson, E Gray, I Mager, R Fischer, ML Thézénas, PD Charles, ... Proteomics 18 (24), 1800257, 2018 | 42 | 2018 |
| CSF chitinases before and after symptom onset in amyotrophic lateral sclerosis E Gray, AG Thompson, J Wuu, J Pelt, K Talbot, M Benatar, MR Turner Annals of clinical and translational neurology 7 (8), 1296-1306, 2020 | 38 | 2020 |
| Higher blood high density lipoprotein and apolipoprotein A1 levels are associated with reduced risk of developing amyotrophic lateral sclerosis AG Thompson, K Talbot, MR Turner Journal of Neurology, Neurosurgery & Psychiatry 93 (1), 75-81, 2022 | 36 | 2022 |
| Genetic testing in motor neurone disease T Dharmadasa, J Scaber, E Edmond, R Marsden, A Thompson, K Talbot, ... Practical neurology 22 (2), 107-116, 2022 | 34 | 2022 |
| An ALS-linked mutation in TDP-43 disrupts normal protein interactions in the motor neuron response to oxidative stress E Feneberg, D Gordon, AG Thompson, MJ Finelli, R Dafinca, A Candalija, ... Neurobiology of disease 144, 105050, 2020 | 32 | 2020 |
| Initial identification of a blood-based chromosome conformation signature for aiding in the diagnosis of amyotrophic lateral sclerosis M Salter, E Corfield, A Ramadass, F Grand, J Green, J Westra, CR Lim, ... EBioMedicine 33, 169-184, 2018 | 26 | 2018 |
| A risk stratifying tool to facilitate safe late-stage percutaneous endoscopic gastrostomy in ALS AG Thompson, V Blackwell, R Marsden, E Millard, C Lawson, AH Nickol, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18 (3-4), 243-248, 2017 | 20 | 2017 |
| Creatine kinase and prognosis in amyotrophic lateral sclerosis: A literature review and multi-centre cohort analysis J Gao, T Dharmadasa, A Malaspina, PJ Shaw, K Talbot, MR Turner, ... Journal of Neurology 269 (10), 5395-5404, 2022 | 15 | 2022 |
Kevin TalbotProfessor of Neurology, Oxford UniversityGeverifieerd e-mailadres voor ndcn.ox.ac.uk